CyDex Pharmaceuticals
Latest round
- Series B
Last raised
- Aug 2004
Total raised
- $17M
Investors
- 5
About CyDex Pharmaceuticals
CyDex Pharmaceuticals, Inc. specializes in developing innovative pharmaceutical solutions aimed at enhancing drug delivery and efficacy.CyDex Pharmaceuticals, Inc. operates out of Lenexa, US, and is engaged in the pharmaceutical sector, focusing on advanced drug delivery technologies. The company was acquired by Ligand Pharmaceuticals, Inc.2 million.The company primarily focuses on delivering innovative solutions through its core product offerings, which are designed to address specific challenges faced by its clientele. These offerings encompass advanced drug delivery systems which aim to enhance operational efficiencies and user experiences across various sectors. The company targets businesses in the pharmaceutical market, providing tailored solutions that meet the needs of diverse industries, such as oncology and pain management. With a client base that includes pharmaceutical companies, the end users benefit from the practical applications of the company’s products, which have been well-received since their release in the early 2000s.The revenue model of the company is primarily based on B2B transactions. Transactions typically occur through contracts which enable clients to access the company’s flagship offerings, such as its proprietary drug delivery technologies. Pricing strategies are structured to accommodate various client needs, with different tiers available for specific products or services.CyDex Pharmaceuticals is planning to expand its product line with new drug delivery solutions, with potential launches anticipated by the end of 2023. The company is also focusing on entering new markets within Europe and Asia by 2024.
Who invested in CyDex Pharmaceuticals
5 investors across 1 round
See all investors in CyDex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 17, 2004
Amount
$17M
Investors
Questions about CyDex Pharmaceuticals
Who invested in CyDex Pharmaceuticals?
CyDex Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CyDex Pharmaceuticals raised?
CyDex Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CyDex Pharmaceuticals last raise money?
CyDex Pharmaceuticals's most recent round on record is a Series B, in Aug 2004.
What does CyDex Pharmaceuticals do?
CyDex Pharmaceuticals is a pharmaceuticals company.
Where is CyDex Pharmaceuticals headquartered?
CyDex Pharmaceuticals is headquartered in Lenexa, US.
Which VCs invest in companies like CyDex Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CyDex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like CyDex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.